AN ARTICLE ON PHARMACIST CLNICAL REVIEW PROCESS
Staffingly, Inc
?? Virtual Medical Assistants ?? Insurance ? Prior Authorization ?? Data Entry/Coding ?? Telemedicine ?? RCM
?
CLINICAL PHARMACIST:?Pharmacist is the bridge between doctors and patients who counsels and advice the patient to maximize the desired effect of the drugs and minimize the adverse effects of the drug.
The basic duty of a pharmacist is to check prescriptions from physicians before dispensing the medication to the patients to ensure that the patients don’t receive the wrong drugs or take an incorrect dose of medicine. Dispensing the wrong drugs or giving incorrect usage instructions can have serious consequences for patients, including death. Pharmacists also offer guidance on the side effects; medication can have and warn against actions that could be dangerous while the patient is using the medicine, such as consuming alcohol or operating heavy machinery.
ROLE OF CLINICAL PHARMACIST:
Pharmacist should always associate as a team member of health care professionals. Pharmacist is an expert person in decision-making process in matters of dosage regimens, monitoring of adverse drug reactions, interactions with medications, and interpretation of prescriptions as well as associated with drug and poison information services.
RESPONSIBILITIES OF CLINICAL PHARMACIST:
Pharmacist should participate with physicians, he should do visit alone to provide information related with medication and its administration and necessary care to concerned patient.
THE RELATIONSHIP OF TRAID
CLINICAL REVIEW:
Clinical review is a system review or relevant information of all examination done by clinical pharmacist on response and monitoring of drug treatment and safety aspect on daily basis. The main approach of clinical review is to assess the therapeutic outcome of the dosage regimen and its safety. It is one of the integral parts of the medication chart review.
GOALS OF CLINICAL REVIEW:
Following are the primary goals of the clinical review:
CRITERIA FOR EFFECTIVE PHARMACIST CLINICAL REVIEW:
Pharmacists have expertise and advanced training in the effective and appropriate use of medications. Following are some important criteria for effective clinical review:
For example: pharmacist run anticoagulant clinics
Many pharmacist run anticoagulant clinics in developed countries. In their clinics, they estimate international normalized ratio (INR) for the patients who are an anticoagulant therapy. If INR is found more than normal, the dose of the patient is altered and if situation demands, the pharmacist may discuss the report with the patients G.P. for necessary treatment corrections.
MEDICATION REVIEW:
“Medication review is a structured evaluation of a patient’s medicines with the aim of optimizing medicines use and improving health outcomes. This entails detecting drug-related problems and recommending interventions”.
Medication review services are fast becoming popular in many countries, and are known for giving pharmacists basic knowledge as well as a practical exercise in delivering an additional service to their patients. Pharmacists who have successfully completed a follow-up or continuing education course may offer these services.
MEDICATION REVIEW PROCESS:
To evaluate the successes and barriers of the implementation of a pharmacist-led full medication review process in hospitals. The process consisted of three steps:
The difference between the medical reconciliation and medication review are given below:
The Institute for Safe Medication Practices Canada (ISMP) states that: “Medication reconciliation is intended to prevent medication errors at transition points in patient care, whereas medication review is intended to address drug-related problems arising over time.”
领英推荐
MEDICATION CHART REVIEW:
Medication chart review (MCR) is a fundamental responsibility of pharmacist to ensure appropriate medication order. The main objective of MCR are to optimizing the drug therapy, improving the health outcomes and reduce the medical related problems like untreated indications, inappropriate drug selection, drug interaction, overdose of any medication; and any errors that may occurs while prescribing of drug therapy and administration.
If the pharmacist found any errors or problem in medication chart then should write annotations on the chart at appropriate place where medication order is unclear.
MEDICATION HISTORY:
Details information about medication history in terms of questions asked by pharmacist while interviewing the patients, type of information recorded in medical history.
Patient medication history provides the valuable information on the patient’s allergic tendency, patient compliance and self- medication. Such type of information of medication history helps the pharmacist to establish with patient, commencing of patient counseling and designing of pharmaceutical care plan.
PHARMACIST INTERVENTION:
Pharmacist intervention covers wide range of medication related issues. There is a necessary of pharmacist intervention to detect any problem with the medication therapy. In patient care services, there recognizes various untreated health issues and this can be resolved by choosing appropriate therapeutic regimen. Pharmacists follow the progress of therapeutic outcome.
Pharmacist involved in the review of prescription and if needed suggest the appropriate therapeutic regimen to improve the safety, efficacy as well as cost of medications. Method of pharmacist intervention considered has great inputs in the patient care system. In this, pharmacist role is to reduce the medication errors, justifying the use of therapeutic regimen in particular patient and reducing the cost of medications.
There have diversified role of pharmacist including the dispensing of medication, patient monitoring, patient counseling, health education, community services and clinical practices. It is recommended that all the prescription must be reviewed by the pharmacist before dispensing of medication to avoid the medication errors.
Importance of pharmacist intervention:
Medication errors may cause the consequences which may range from minor to seriousness and sometimes may require hospitalization or death of patient. Pharmacist intervention may reduce to this happen. Following are some objectives of pharmacist intervention.
PHARMACEUTICAL CARE:
Pharmaceutical care is a practice of pharmacist to contribute to optimize the rational therapy towards improvement in the health status of patients. The major goal and output of the pharmaceutical care are, elimination or prevention of the disease symptoms, cure or slowing of disease condition.
The pharmaceutical care plan is prepared on the basis of clearly defined therapeutic goal. The pharmaceutical care plan is made in the form of written, individualized and comprehensive medication therapy. The responsibility of pharmaceutical care plan is delivered to pharmacists who are involved in direct patient care and is updated with each major change in patient status.
Functions of pharmaceutical care plan:
Following are the three main functions of pharmaceutical care plan:
For example, the outcomes associated with pharmacist involvement in diabetes care in all pharmacy practice settings.
A total of 120 patients consented to participate in this randomized control study (fig. 1). Of the 120 patients, 20 patients were excluded. In the intervention group, 39 patients completed the eight visits with the pharmacists. On the other hand, 37 patients in the non-intervention group completed this study. The study observed the changes of glycaemic control, body mass index (BMI) and blood pressure within and between groups. The changes of lipid profile and adherence were only analyzed in intervention group as there was not sufficient data in non-intervention group. There were no differences of baseline HbA1c and FBG between groups.
FIG: 1 Enrollment Randomization control study
The mean HbA1c in the intervention group decreased significantly. However, the reduction of mean HbA1c in the non-intervention group was not significant. The mean HbA1c reduction of in the intervention group was significantly different than the reduction in the nonintervention group. Sixteen patients had significantly achieved at least 1% drop in HbA1c in the intervention group as compared to eight patients in the non-intervention group (fig. 2).
In addition, the FBG was significantly improved in the intervention group with a reduction and there was significant difference of mean FBG between the intervention and non-intervention groups
FIG: 2?Percentage of patients with a specified reduction in HbA1c
The difference of systolic blood pressure was significant between groups with the reduction of mean systolic blood pressure in the intervention group but elevated systolic blood pressure in non-intervention group. Both groups had improvement in diastolic blood pressure but the results were not significant within and between groups. The body mass index reduction was not significant in the intervention group but increased insignificantly in the non-intervention group and the difference between the groups was not significant.
There was a significant reduction of in mean total cholesterol in intervention group. Mean LDL cholesterol also reduced significantly. However, there were no significant changes in the TG and HDL cholesterol. New insulin cases were significantly higher in the intervention group as compared to the non-intervention group. Majority of the patients had addition of basal insulin.
CONCLUSION:
These findings provide evidence of the effectiveness of pharmaceutical care in diabetes and suggest that pharmacists shall expand their service, especially to patients with uncontrolled diabetes. The greatest improvements occur when pharmacists work in collaborative practice models. Growing evidence demonstrates that pharmacists, working as educators, consultants, or clinicians in partnership with other healthcare professionals, are able to contribute to improved patient outcomes.